Research showed links between smoking heavily and developing genetic mutations and a greater risk for myelodysplastic ...
The relationship between heteroplasmy and clonal hematopoiesis of indeterminate potential and its association with the incidence of myeloid neoplasms ... in patients with myelodysplastic syndromes ...
Patients with myelodysplastic neoplasms (MDS) suffer from a disruption in the healthy maturation of blood cells in their bone marrow. This can lead to anemia, infections and an increased risk of ...
Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose – and are commonly misdiagnosed – putting patients at increased risk for treatment mistakes and ...
The models were tested ... The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality ...
For this reason, current evidence-based recommendations from international medical societies and the German Society of Hematology and Medical Oncology (DGHO) (Myelodysplastic Neoplasms ...
“Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic ...